BABayer Aktiengesellschaft BAYRY · OTC
$12.51 +1.46% (+$0.18)
- Market cap
- 43.2B €
- Enterprise value
- 77.3B €
- P/E
- -
- Forward P/E
- 9.6x
- PEG
- -
- P/S
- 0.9x
- P/FCF
- 65.1x
- EV/EBITDA
- 8.5x
- ROIC
- 9.1%
- Gross margin
- 59.1%
- Net margin
- -3.6%
- Dividend yield
- 0.26%
- Payout ratio
- -
- Net debt/EBITDA
- 3.7x
- Beta
- 0.83
- Free float
- 25.0%
About the company
Bayer Aktiengesellschaft is a German multinational pharmaceutical and chemical company headquartered in Leverkusen, founded in 1863. Bayer is known for its wide range of products in healthcare, agriculture, and materials science. The company specializes in the development and manufacture of pharmaceutical drugs, vaccines, agrochemicals, and highly specialized materials, such as plastics and polymers. Bayer is a leader in research and innovation, particularly in oncology, cardiology, and biological sciences. With a global presence, the company operates in many countries worldwide, focusing on sustainable and innovative solutions for health and agriculture.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bill Anderson
Employees
88,078
Headquarters
Leverkusen
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number